Butler Hall Capital LLC has issued a 2nd letter to the board of directors of Vanda Pharmaceuticals, urging the Board to immediately form an independent special committee to run a full sales process to achieve the highest possible value for shareholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VNDA:
- Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
- Vanda Pharmaceuticals confirms receipt of takeover proposal from Future Pak
- Vanda Pharmaceuticals Considers Cycle Group’s Preliminary Interest
- Vanda Pharmaceuticals receives indication of interest for $8.00 per share
- Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.